Form 4: Privia Health Director Receives Equity Grant Under Incentive Plan

Privia Health Group, Inc. Director Patricia Anne Maryland was granted 8,396 restricted stock units on May 21, 2025, as part of the company's 2021 Omnibus Incentive Plan.

Summary

• Patricia Anne Maryland, a Director of Privia Health Group, Inc. (PRVA), acquired 8,396 shares of common stock through a grant of restricted stock units (RSUs).
• The transaction occurred on May 21, 2025, with a reported price of $0 per share, indicating a grant rather than a purchase.
• These restricted stock units were issued under the Issuer's 2021 Omnibus Incentive Plan.
• Following this transaction, Ms. Maryland beneficially owns a total of 42,312 shares of Privia Health Group, Inc. common stock.
• The RSUs are set to vest on the earlier of (i) the day immediately preceding the Company's 2026 annual meeting of stockholders or (ii) the first anniversary of the grant date (May 21, 2025).

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as it indicates standard corporate governance practices and aligns director interests with shareholders, which is generally viewed favorably. However, it's a routine transaction and not indicative of significant operational or financial changes.

Positives

• The grant of restricted stock units to a director aligns their interests with those of long-term shareholders, as the value of the compensation is tied to the company's stock performance.
• This is a standard practice in corporate governance to incentivize directors and retain talent.

Future Outlook

The restricted stock units granted to the director are subject to a future vesting schedule, which will occur on the earlier of the day preceding the Company's 2026 annual meeting of stockholders or the first anniversary of the grant date (May 21, 2025).

Industry Context

This Form 4 filing details a routine insider transaction, specifically an equity grant to a director, which is a common practice across various industries to compensate and incentivize board members. Such grants are typically part of a company's long-term incentive plan, aiming to align the interests of directors with shareholder value creation.

Comparison to Industry Standards

• The grant of restricted stock units to a director is a standard component of compensation packages for board members across publicly traded companies, including those in the healthcare services sector like Privia Health Group, Inc.
• This practice is consistent with corporate governance best practices that seek to align the financial interests of directors with the long-term performance of the company and its shareholders.
• While specific comparable companies or projects are not detailed in this filing, similar equity compensation structures are observed at peers such as One Medical (acquired by Amazon), Oak Street Health (acquired by CVS Health), and other physician enablement or value-based care providers.

Corporate Governance

Related Party Transactions

• The grant of 8,396 restricted stock units to Patricia Anne Maryland, a Director of Privia Health Group, Inc., constitutes a related party transaction as it involves compensation from the company to a member of its board of directors. This is a standard and disclosed form of director compensation.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's financial incentives with shareholder interests, potentially leading to decisions that enhance long-term stock value.
• Employees: While not directly impacted, the incentive plan framework may set precedents for broader employee equity compensation programs.

Next Steps

• The restricted stock units will vest on the earlier of the day immediately preceding the Company's 2026 annual meeting of stockholders or the first anniversary of the grant date (May 21, 2025).

Key Dates

Recommendation

Keywords

Privia Health Group, PRVA, SEC Form 4, Insider Transaction, Restricted Stock Units, Equity Grant, Director Compensation, Incentive Plan, Beneficial Ownership